维普期刊资源整合服务平台（V6.5）

69篇 您的检索式：作者名="Bubnoff"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Antigen-presenting cells in allergy显示文摘	von Bubnoff D Geiger E Bieber T	2001	J Allergy Clin Immunol2001，108，：	1
2	Antigen-presenting cells in allergy显示文摘	von Bubnoff D Geiger E Bieber T	2001	J Allergy Clin Immunol2001，108，3：	1
3	Successful allogeneic stem cell transplantation in second chronicphase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib显示文摘	Menzel H von Bubnoff N Hochhaus A		Bone Marrow Transplantation0，，：	1
4	Fc epsilon RI induces the tryptophan degradation pathway involved in regulating T cell responses显示文摘	von Bubnoff D Matz H Frahnert C	2002	J Immunol2002，169，4：	1
5	lntracellular BMP signaling regulation in vertebrates : pathway or network? 显示文摘	Von Bubnoff A Cho K W	2001	Dev Biol2001，239，1：	1
6	Intracellular BMP signaling regulation in vertebrates: pathway or network显示文摘	Von Bubnoff A Cho KW	2001	Dev Biol2001，239，：	1
7	Natural killer cells in atopic and autoimmune diseases of the skin显示文摘	von Bubnoff D Andrès E Hentges F		0，，01：	1
8	Combination of inmtinib with rapamycin or RADO0I acts synergistically only in Bcr-Abl positive cells with moderate resistance to imatinib 显示文摘	Dengler J von Bubnoff N Decker T	2005	l eukemia2005，19，10：	1
9	Seeking new antibiotic in nature's backyard显示文摘	von Bubnoff A	2006	Cell2006，127，5：	1
10	The systemic mastocytosis-specific activating eKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107 显示文摘	VON BUBNOFF N GORANTLA SH KANCHA RK	2005	Leukemia2005，19，9：	1
11	Topical tacrolimas(FK505) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis 显示文摘	Olhnberg A Sharma S von Bubnoff D	2001	AUergy Clin Immunol2001，107，3：	1
12	Topical tacrolimas(FK506) leads toprofound phenotypic and functional alteration of epidermal antigen-presenting dendritic cells in atopic dermatitis显示文摘	Wollenberg A Sharma S von Bubnoff D		0，，03：	1
13	Resistance of Philadelphia-chronmosome positive leukemia towards the kinase inhibitor imatinib (STI571) ,Glivec) :a targeted oncoprotein striles back 显示文摘	VOO BUBNOFF N PESCHEL C DUYSTER J	2003	Leukemia2003，17，：	1
14	Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle显示文摘	von Bubnoff D Hanau D WenzelJ	2003	J Allergy Clin Immunol2003，112，5：	1
15	Asia squeezes Europe's lead in science显示文摘	Andreas yon Bubnoff Washington DC	2005	Nature2005，436，7049：	1
16	Topical tacrolimus(FK506) leads to profound phenotypic and functional alterations of antigertpreseming dendritic cells in atopic dermatitis显示文摘	WOLLENBERG A SHARMA S VON BUBNOFF D	2001	] Allergy Clin Immunoi2001，107，3：	1
17	Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling 显示文摘	Yoshida Y von Bubnoff A Ikematsu N	2003	Mech Dev2003，120，5：	1
18	Resistance of Philadelphia chromosone positive leukemia towards the kinase inhibitor imatinib (ST1571,Glivec):a target oncoprotein strikes back显示文摘	Von Bubnoff N Peschel C Duyster J	2003	Leukemia2003，17，5：	1
19	Rosistence of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib ( ST1571,Glivec) : a targeted oncoproteln strikes back 显示文摘	Von Bubnoff N Peschel C Duyster J	2003	Leukemia2003，17，5：	1
20	FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro 显示文摘	von Bubnoff N Engh RA Aberg E	2009	Cancer Res2009，69，7：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示